Perceptions, attitudes and beliefs among allied healthcare professionals managing people with Type 2 diabetes: an international cross-sectional survey
Keywords:Survey, Diabetes management, Glucose control, Barriers, Attitudes, Allied healthcare professionals
Introduction: Many individuals with Type 2 diabetes (T2DM) do not achieve their glycaemic targets, and allied healthcare professionals (HCPs) have a central role in their care.
Methods: Allied HCPs who advise/treat people with T2DM completed a cross-sectional, Internet-based survey to examine clinical practice patterns and identify barriers to achieving glycaemic control. Responses from 280 allied HCPs from 51 countries were analysed.
Results: Participants were mostly from North America (46%), Australia/Oceania (17%) and Europe (16%). Many (65%) respondents reported that ≤60% of their patients achieve their HbA1c targets. Lack of motivation by HCPs and patients, as well as poor patient adherence to therapy, were identified as major barriers to achieving glycaemic targets. Strategies most frequently selected by HCPs to improve glycaemic outcomes were patient-focused.
Conclusions: Greater awareness among HCPs of their role in supporting and motivating patients to self-manage their condition may improve rates of glycaemic control among individuals with T2DM.
International Diabetes Federation. IDF Diabetes atlas seventh edition; 2015. [cited 2017 Sep 1]. Available from http://www.diabetesatlas.org/.
Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–22. doi: 10.1038/nrendo.2016.105
Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–200. doi: 10.7150/ijms.10001
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79. doi: 10.2337/dc12-0413
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. doi: 10.1016/S0140-6736(98)07019-6
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89. doi: 10.1056/NEJMoa0806470
Bailey CJ, Aschner P, Del Prato S, LaSalle J, Ji L, Matthaei S. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diab Vasc Dis Res. 2013;10(5):397–409. doi: 10.1177/1479164113490765
Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32(5):442–58. doi: 10.1002/dmrr.2827
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2013;37(Suppl. 1):S1–S212.
Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract. 2005;59(11):1345–55. doi: 10.1111/j.1742-1241.2005.00674.x
Del Prato S, LaSalle J, Matthaei S, Bailey CJ. Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int J Clin Pract. 2010;64(3):295–304. doi: 10.1111/j.1742-1241.2009.02227.x
Bailey CJ, Del Prato S, Eddy D, Zinman B. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract. 2005;59(11):1309–16. doi: 10.1111/j.1742-1241.2005.00675.x
Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol. 2010;47(2):137–45. doi: 10.1007/s00592-009-0138-z
Felton AM, LaSalle J, McGill M. Treatment urgency: the importance of getting people with type 2 diabetes to target promptly. Diabetes Res Clin Pract. 2016;117:100–3. doi: 10.1016/j.diabres.2016.04.026
Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Vokó Z, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105(3):302–12. doi: 10.1016/j.diabres.2014.05.005
Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673–79. doi: 10.2337/diacare.28.11.2673
Holt RI, Nicolucci A, Kovacs Burns K, Escalante M, Forbes A, Hermanns N, et al. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care-healthcare professional perspective. Diabet Med. 2013;30(7):789–98. doi: 10.1111/dme.12242
Peytremann-Bridevaux I, Lauvergeon S, Mettler D, Burnand B. Diabetes care: opinions, needs and proposed solutions of Swiss patients and healthcare professionals: a qualitative study. Diabetes Res Clin Pract. 2012;97(2):242–50. doi: 10.1016/j.diabres.2012.02.021
How to Cite
Copyright (c) 2017 Foundation of European Nurses in Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.